Keyphrases
Surveillance Epidemiology
100%
Single-center Experience
100%
End Results Database
100%
Pulmonary Marginal Zone Lymphoma
100%
Lymphoma
75%
Lymphoid Tissue
75%
Rare Diseases
50%
Disease Progression
25%
Progression-free Survival
25%
No Significant Difference
25%
Overall Survival
25%
Median Overall Survival
25%
Retrospective Review
25%
Limited Information
25%
Single Institution
25%
Kaplan-Meier Estimator
25%
Partial Remission
25%
In(III)
25%
Combination Chemotherapy
25%
Rituximab
25%
Radioimmunotherapy
25%
Clinical Presentation
25%
Median Survival
25%
Biopsy-proven
25%
Stable Disease
25%
Disease-specific
25%
Complete Remission
25%
Natural History
25%
Disease-specific Survival
25%
Stage IV Disease
25%
Natural Treatment
25%
Disease Stage
25%
Initial Management
25%
Favorable Outcome
25%
3-stage
25%
Medicine and Dentistry
Surveillance, Epidemiology, and End Results
100%
MALT Lymphoma
100%
Diseases
100%
Lymphatic Tissue
75%
Overall Survival
50%
Rare Disease
50%
Progression Free Survival
25%
Disease Exacerbation
25%
Kaplan Meier Method
25%
Combination Chemotherapy
25%
Rituximab
25%
Disease Specific Survival
25%
Radioimmunotherapy
25%
Biopsy Technique
25%